Literature DB >> 23239576

Molecular dissection of a viral quasispecies under mutagenic treatment: positive correlation between fitness loss and mutational load.

Armando Arias1,2, Ana Isabel de Ávila2, Marta Sanz-Ramos3,2, Rubén Agudo4,2, Cristina Escarmís2, Esteban Domingo5,2.   

Abstract

Low fidelity replication and the absence of error-repair activities in RNA viruses result in complex and adaptable ensembles of related genomes in the viral population, termed quasispecies, with important implications for natural infections. Theoretical predictions suggested that elevated replication error rates in RNA viruses might be near to a maximum compatible with viral viability. This fact encouraged the use of mutagenic nucleosides as a new antiviral strategy to induce viral extinction through increased replication error rates. Despite extensive evidence of lethal mutagenesis of RNA viruses by different mutagenic compounds, a detailed picture of the infectivity of individual genomes and its relationship with the mutations accumulated is lacking. Here, we report a molecular analysis of a foot-and-mouth disease virus population previously subjected to heavy mutagenesis to determine whether a correlation between increased mutagenesis and decreased fitness existed. Plaque-purified viruses isolated from a ribavirin-treated quasispecies presented decreases of up to 200-fold in infectivity relative to clones in the reference population, associated with an overall eightfold increase in the mutation frequency. This observation suggests that individual infectious genomes of a quasispecies subjected to increased mutagenesis lose infectivity by their continuous mutagenic 'poisoning'. These results support the lethal defection model of virus extinction and the practical use of chemical mutagens as antiviral treatment. Even when extinction is not achieved, mutagenesis can decrease the infectivity of surviving virus, and facilitate their clearance by host immune responses or complementing antiviral approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239576     DOI: 10.1099/vir.0.049171-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Contribution of a Multifunctional Polymerase Region of Foot-and-Mouth Disease Virus to Lethal Mutagenesis.

Authors:  Ignacio de la Higuera; Cristina Ferrer-Orta; Elena Moreno; Ana Isabel de Ávila; María Eugenia Soria; Kamalendra Singh; Flavia Caridi; Francisco Sobrino; Stefan G Sarafianos; Celia Perales; Nuria Verdaguer; Esteban Domingo
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

2.  High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy.

Authors:  Weihua Wang; Xiaoan Zhang; Yanjuan Xu; George M Weinstock; Adrian M Di Bisceglie; Xiaofeng Fan
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

3.  Lethal mutagenesis of an RNA plant virus via lethal defection.

Authors:  Luis Díaz-Martínez; Isabel Brichette-Mieg; Axier Pineño-Ramos; Guillermo Domínguez-Huerta; Ana Grande-Pérez
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

4.  Molecular and Functional Bases of Selection against a Mutation Bias in an RNA Virus.

Authors:  Ignacio de la Higuera; Cristina Ferrer-Orta; Ana I de Ávila; Celia Perales; Macarena Sierra; Kamalendra Singh; Stefan G Sarafianos; Yves Dehouck; Ugo Bastolla; Nuria Verdaguer; Esteban Domingo
Journal:  Genome Biol Evol       Date:  2017-05-01       Impact factor: 3.416

5.  Influence of Ribavirin on Mumps Virus Population Diversity.

Authors:  Mirna Jurković; Anamarija Slović; Dubravko Forčić; Jelena Ivančić-Jelečki; Tanja Košutić-Gulija; Maja Jagušić
Journal:  Viruses       Date:  2021-12-17       Impact factor: 5.048

6.  Rare haplotype load as marker for lethal mutagenesis.

Authors:  Josep Gregori; María Eugenia Soria; Isabel Gallego; Mercedes Guerrero-Murillo; Juan Ignacio Esteban; Josep Quer; Celia Perales; Esteban Domingo
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.